timothy sykes logo
AVAV Stock Jumps As Laser Weapon Contracts Fuel Growth Thumbnail

AVAV Stock Jumps As Laser Weapon Contracts Fuel Growth

BRYCE TUOHEYUPDATED SEP. 10, 2026, 3:03 PM ET
Reviewed by Tim Sykesand Fact-checked by Matt Monaco

AeroVironment Inc. stocks have been trading up by 7.13 percent amid strong defense-contract momentum and upbeat market sentiment.

Key Takeaways For AVAV Traders

  • Record Q1 FY27 revenue hit $480.5M, up 6% year over year, with non-GAAP EPS climbing to $0.59 and funded backlog reaching a record $1.5B, up 37% versus last year.
  • Quarterly bookings of $0.7B delivered a 1.4x book-to-bill ratio, showing demand for AeroVironment’s systems is running ahead of current revenue.
  • A landmark $464.8M U.S. Army Enduring-High Energy Laser production deal moves AVAV’s LOCUST X3 laser weapons from prototypes into multi-year large-scale deployment.
  • The first international LOCUST laser order above $50M adds a new global revenue stream and validates AVAV’s counter-drone tech outside the U.S. defense market.
  • A NASA/JPL SkyFall contract for three Mars helicopters extends AeroVironment’s MacCready Works brand in space robotics and reinforces AVAV’s innovation story for traders.

Candlestick Chart

Live Update At 15:02:32 EDT: On Thursday, September 10, 2026 AeroVironment Inc. stock [NASDAQ: AVAV] is trending up by 7.13%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

AeroVironment Inc. and ticker AVAV just backed up the hype with hard numbers. For Q1 FY27, the company posted revenue of $480.5M, up 6% year over year and ahead of expectations. Adjusted EPS came in at $0.59, smashing the roughly mid-$0.20s Street view. That kind of surprise often gets traders’ attention fast.

Even more important for AVAV, bookings hit $0.7B. That created a 1.4 book-to-bill ratio, meaning new orders are stacking up faster than revenue is going out the door. Funded backlog climbed to a record $1.5B, up 37% from a year earlier, giving AVAV unusual visibility on future sales.

On the chart, AVAV has been volatile but constructive. After trading as high as the low $190s in late August, the stock pulled back into the mid-$140s, then bounced to close near $150.84 on 2026/09/10. Intraday action shows strong dip buying from the $142.50 low back toward the mid-$150s before some late-day cooling. For active trading, that tells you momentum is still alive, but dip entries matter.

Margin-wise, AVAV is still cleaning up its income statement. GAAP results show a small net loss of $5.1M this quarter, but that is a huge improvement from a $67.4M loss previously. Gross margin expanded from 21% to 26%, thanks in part to lower amortization on past acquisitions. For traders, the key is direction: losses are shrinking and cash flow is improving.

Why Traders Are Watching AVAV Now

AVAV is not just another defense name grinding out small drone orders. The real story now is lasers and backlog.

The big catalyst is the $464.8M U.S. Army Enduring-High Energy Laser (E-HEL) contract. Under this deal, AeroVironment will deliver dozens of LOCUST X3 high‑energy laser weapon systems over several years. This is the first large-scale U.S. production award for directed‑energy weapons, and AVAV is sitting in the lead chair. That shifts the company from experimental prototypes to real deployment, with multi-year revenue visibility locked in.

On top of that, AVAV landed its first international direct commercial sale for LOCUST worth more than $50M. Management is also putting over $30M into expanding manufacturing capacity for these laser systems. That tells traders demand is not a one-off; AVAV is scaling up because it already has the orders.

The earnings beat ties straight into this story. With a record $1.5B funded backlog and $0.7B in new bookings, AVAV is building a pipeline that supports its reaffirmed FY27 guidance of $2.125B–$2.225B in revenue and EPS of $3.02–$3.34. The company didn’t rush to hike guidance after the beat. Instead, it confirmed its range, which usually signals confidence without hype.

Short term, the market liked what it saw. AVAV shares jumped roughly 4% after the print and guidance confirmation, then continued to trade actively in the $140–$160 band. For momentum traders, that combination of strong news, rising volume, and clear catalysts often sets up multi-day opportunities, especially if dips into support get bought again.

There is optionality, too. AVAV’s MacCready Works unit won a NASA/JPL deal to co-design and co-build three autonomous Mars helicopters for the SkyFall mission planned for 2028. That work won’t move near-term revenue much, but it reinforces AeroVironment’s edge in advanced robotics and aerospace, which can support a strategic premium in the stock over time.

Macro tailwinds add another layer. New U.S. tariffs of up to 100% on heavier and thermal‑imaging drones and 25% on smaller drones mostly hit Chinese suppliers. Domestic players like AVAV stand to benefit as U.S. and allied buyers look closer to home for drone and counter‑drone solutions.

Conclusion

For active traders, AVAV now sits at the crossroads of three powerful themes: directed‑energy weapons, counter‑drone demand, and high‑end aerospace robotics. The $464.8M E‑HEL contract and the $50M‑plus international LOCUST order push AeroVironment into a leadership role in laser-based air defense. The record $1.5B backlog and strong Q1 beat show this is not just a story; it is already flowing through the numbers.

At the same time, AVAV is still working through GAAP losses and heavy prior acquisition costs. Margins are improving, but this is a growth build-out, not a finished cash cow. The balance sheet looks solid, with low debt relative to equity and plenty of liquidity, which supports the ongoing $30M plus capacity expansion for LOCUST production.

For short-term trading, AVAV’s recent spike, 4% post-earnings move, and intraday swings around $150 create both momentum and trap risk. As Tim Sykes loves to remind traders, “The market doesn’t care about your opinion, only your plan—cut losses quickly and let the best setups come to you.” That mindset lines up with his broader focus on capital preservation; as millionaire penny stock trader and teacher Tim Sykes, says, “It’s not about how much money you make; it’s about how much money you keep.”. With AVAV, the plan means tracking key price levels, monitoring follow‑through on these contracts, and treating every entry and exit as part of a risk-managed game. This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:


How much has this post helped you?



Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”